These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34634760)

  • 41. Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations.
    Albrecht S; Bogdanovic N; Ghetti B; Winblad B; LeBlanc AC
    J Neuropathol Exp Neurol; 2009 Dec; 68(12):1282-93. PubMed ID: 19915487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
    Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
    Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein.
    Kishimoto Y; Kirino Y
    Neurosci Lett; 2013 Mar; 538():15-9. PubMed ID: 23370287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties.
    Mahairaki V; Ryu J; Peters A; Chang Q; Li T; Park TS; Burridge PW; Talbot CC; Asnaghi L; Martin LJ; Zambidis ET; Koliatsos VE
    Stem Cells Dev; 2014 Dec; 23(24):2996-3010. PubMed ID: 25027006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Genetics of dementias, Part 4: a spectrum of mutations responsible for the familial autosomal dominant form of Alzheimer's disease].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():583-91. PubMed ID: 20009122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
    Yin J; VanDongen AM
    ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.
    Yu CE; Marchani E; Nikisch G; Müller U; Nolte D; Hertel A; Wijsman EM; Bird TD
    Arch Neurol; 2010 May; 67(5):631-3. PubMed ID: 20457965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment.
    Lindquist SG; Hasholt L; Bahl JM; Heegaard NH; Andersen BB; Nørremølle A; Stokholm J; Schwartz M; Batbayli M; Laursen H; Pardossi-Piquard R; Chen F; St George-Hyslop P; Waldemar G; Nielsen JE
    Eur J Neurol; 2008 Oct; 15(10):1135-9. PubMed ID: 18727676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-onset Alzheimer's disease.
    Achouri-Rassas A; Ben Ali N; Fray S; Hadj Fredj S; Kechaou M; Zakraoui NO; Cherif A; Chabbi S; Anane N; Messaoud T; Gouider R; Belal S
    Neurobiol Aging; 2015 Oct; 36(10):2904.e9-11. PubMed ID: 26145164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.
    Yescas P; Huertas-Vazquez A; Villarreal-Molina MT; Rasmussen A; Tusié-Luna MT; López M; Canizales-Quinteros S; Alonso ME
    Neurogenetics; 2006 Jul; 7(3):195-200. PubMed ID: 16628450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.
    Hin N; Newman M; Kaslin J; Douek AM; Lumsden A; Nik SHM; Dong Y; Zhou XF; Mañucat-Tan NB; Ludington A; Adelson DL; Pederson S; Lardelli M
    PLoS One; 2020; 15(1):e0227258. PubMed ID: 31978074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of Alzheimer's disease.
    Alonso Vilatela ME; López-López M; Yescas-Gómez P
    Arch Med Res; 2012 Nov; 43(8):622-31. PubMed ID: 23142261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I).
    Janicki S; Monteiro MJ
    J Cell Biol; 1997 Oct; 139(2):485-95. PubMed ID: 9334350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Modeling familial Alzheimer's disease with induced pluripotent stem cells].
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Okano H; Suzuki N
    Rinsho Shinkeigaku; 2012; 52(11):1134-6. PubMed ID: 23196540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Setu JR; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Neurotox Res; 2020 Dec; 38(4):833-849. PubMed ID: 32556937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.